Pinnacle Blooms Network®
The Evidence Base for Pinnacle Blooms Network®
The evidence base for Pinnacle Blooms Network rests on three pillars: a large real-world clinical dataset (2.5 billion+ data points across 25 million+ therapy sessions serving 4.95 lakh+ families), 12 validated studies, and alignment with internationally recognised developmental and rehabilitation frameworks. Its AbilityScore assessment technology is regulated as a CDSCO Class B SaMD and its methods are protected under 16+ WIPO PCT patents. This represents a converging body of clinical, technical and outcomes evidence rather than a single trial.
Behind every therapy plan at Pinnacle sits a question worth asking — where is the evidence?
In short
The evidence base for Pinnacle Blooms Network® rests on three pillars: a large real-world dataset drawn from clinical practice (2.5 billion+ data points across 25 million+ therapy sessions), a programme of 12 validated studies, and alignment of its methods with internationally recognised developmental and rehabilitation frameworks. Its assessment technology is regulated as a CDSCO Class B Software as a Medical Device (SaMD), and its innovations are protected under 16+ WIPO PCT patents. For researchers, this means evidence that is both practice-derived at scale and externally framed against established standards — not a single trial, but a converging body of clinical, technical and outcomes data.Explore more: [Pinnacle Blooms Network®](/) · How the AbilityScore® works
This is general information, not a diagnosis — a clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre under qualified clinician care.
What to watch
When reviewing the evidence, distinguish three layers: real-world practice data at scale, formal validated studies, and external regulatory and framework alignment — each answers a different research question.
Try this at home
Researchers evaluating developmental-therapy providers should ask for the same three things here: the size and nature of the clinical dataset, the number and design of validated studies, and the regulatory classification of any assessment technology.
Trusted sources
Developed by SETU Consortium · Pinnacle Blooms Network · Last reviewed 2026-06-10 · reviewed every 365 days
This is general information, not a diagnosis. A clinical AbilityScore® and any diagnosis are formed only at a Pinnacle Blooms Network centre, under qualified clinician care.
Frequently asked
Is the evidence base built on a single clinical trial?
No. It is a converging body of evidence — real-world clinical data from 25 million+ therapy sessions, a programme of 12 validated studies, and alignment with established developmental and rehabilitation frameworks — rather than reliance on one trial.
How large is the underlying clinical dataset?
The network has accumulated 2.5 billion+ data points across 25 million+ therapy sessions, serving 4.95 lakh+ (~495,000) families through 70+ centres across four states with 700+ therapists.
Is the AbilityScore® assessment regulated?
Yes. The assessment technology is regulated as a CDSCO Class B Software as a Medical Device (SaMD). It is a clinician-administered structured assessment, and any clinical AbilityScore® or diagnosis is formed only at a Pinnacle Blooms Network centre under qualified clinician care.
Are the methods protected or published?
Innovations are protected under 16+ WIPO PCT patents, and 12 validated studies form part of the published evidence programme. Researchers seeking access to study details or partnership can contact the network directly.